| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. | Director | Common Stock | 35.8K | $26.9K | $0.75 | 28 Nov 2025 | Direct |
| Pasithea Therapeutics Corp. | Director | Stock Option (right to buy) | 42.9K | 24 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | 28 Nov 2025 | 1 | $25K | 4 | Director | 01 Dec 2025, 08:54 |
| KTTA | Pasithea Therapeutics Corp. | 24 Oct 2025 | 1 | $0 | 4 | Director | 27 Oct 2025, 17:25 |
| KTTA | Pasithea Therapeutics Corp. | 01 Mar 2024 | 1 | $0 | 4/A | Director | 05 Apr 2024, 21:45 |
| KTTA | Pasithea Therapeutics Corp. | 01 Mar 2024 | 1 | $0 | 4 | Director | 01 Mar 2024, 21:45 |
| KTTA | Pasithea Therapeutics Corp. | 15 Nov 2022 | 3 | $53.1K | 4 | Director | 17 Nov 2022, 15:34 |
| KTTA | Pasithea Therapeutics Corp. | 14 Sep 2021 | 0 | $0 | 3 | Director | 14 Sep 2021, 21:53 |